The department’s research enterprise is among the largest of its peers in the U.S. It encompasses the full spectrum of translational and public health science and draws from the school’s critical mass of leading faculty and facilities.

The department’s breakthroughs come from faculty members who work full-time in basic science research and from operating surgeons who devote considerable time to basic science or clinical investigations. The department ranks among the top U.S. academic surgery departments in annual NIH, non-federal and corporate-supported grants.

Focused areas of research excellence

  • Breast cancer
  • Cancer biology
  • Cancer epidemiology and public health
  • Cancer immunology
  • Cardiovascular physiology
  • Education
  • Lung transplant immunology
  • Peripheral nerve injury
  • Pancreas cancer
  • Prostate cancer
  • Sepsis and critical injury
  • Vascular biology

130

Active Grants

#2

NIH Funding: Surgery

Blue Ridge Institute 2017

$4.1 M

Clinical Trial Contract Income

543

Active Clinical Trials